Karen Sterling, PhD, CFA, has had a twenty-year career at the intersection of healthcare, biotechnology, and finance. Concurrent to joining Emerging Growth Research, Dr. Sterling also works as a Senior and Supervisory Research Analyst at Kingswood Capital Partners where she has been since 2023. Prior to that, she was Managing Director of Healthcare Investment Banking at Avalon Net Worth, where she practiced strategic advisory, fundraising, and filled transitional C Suite roles for clients.

Dr. Sterling took a 17-month sabbatical from Avalon in 2014-2015 to serve as President & CEO of the New York Society of Security Analysts (nka CFA Society New York), where she orchestrated a financial and operational turnaround of the organization, enhancing its status as a leading finance education forum.

Dr. Sterling holds two Masters degrees and a PhD degree from Columbia University in Biochemistry and Molecular Biophysics and earned her CFA Charter in 2006. She maintains FINRA Series 7, 16, 63, 79, 86, and 87 registrations.